 Home > Active Ingredient News > Infection > Early detection of bacteria in patients with new coronary pneumonia and influenza pneumonia tracheal intubation: a European multicenter cohort study

Early detection of bacteria in patients with new coronary pneumonia and influenza pneumonia tracheal intubation: a European multicenter cohort study

 Last Update: 2021-09-28
 Source: Internet
 Author: User

Tags

journal template

study strategies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The new coronary pneumonia ( COVID-19 ) has had a huge impact on the world.

An article published in the American Journal of Respiratory and Critical Care Medicine , an authoritative respiratory journal, analyzes the early bacterial detection of patients with new coronary pneumonia intubation caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared with influenza pneumonia Outcome rate, as well as microbiological characteristics and their impact on prognosis

The researchers conducted a multicenter retrospective cohort study of 36 ICUs in Europe

A total of 1,050 patients (568 patients with new coronary pneumonia and 482 patients with influenza pneumonia) were included in the study

The bacterial detection rate of severely ill patients with new coronary pneumonia within 48 hours after tracheal intubation is 9.

Original source:

Anahita Rouzé,Ignacio Martin-Loeches, et al, Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial , American Journal of Respiratory and Critical Care Medicine, 2021, https://doi.
org .
/10.
1164/rccm.
202101-0030OC at Anahita Rouzé at Anahita Rouzé of Ignacio Martin-Loeches of Ignacio Martin-Loeches Early Bacterial Identification Among Patients intubated with COVID.
19-or Influenza Pneumonia: A Multicenter Comparative European Clinical Trial

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium benzoate CAS No.532-32-1

CAS No.: 532-32-1

$1380/MT FOB

Api Powder Ketoconazole 98% Powder KETOCONAZOLE API POWDER

CAS No.: 65277-42-1

Pharmacy Grade

$3-3.2/KG FOB

High Purity Trimethoprim CAS 738-70-5 for Bacterial Infections

CAS No.: 738-70-5

Chemical Grade

$3.5-4/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.